Soon you will be seeing giant construction cranes hoisting modules for a new cellular-processing facility onto the East Terrace of the NIH Clinical Center (CC), a.k.a. Building 10. The facility represents the most recent expansion of the CC’s Department of Transfusion Medicine’s (DTM’s) growing capacity to support intramural cellular-therapy protocols.
BY LAURA STEPHENSON CARTER, OD, AND JOANNA CROSS, NIMH
Whether they are studying eye diseases, host-pathogen interactions, neurodegenerative diseases, preventing graft-versus-host disease in stem-cell transplants, blood cancers, pediatric sarcomas, or brain tumors known as gliomas, the eight newest Lasker Clinical Research Scholars are hard at work in labs and clinics throughout NIH. (Pictured: Jing Wu, NCI-CCR.)
The National Institute of Dental and Craniofacial Research (NIDCR) made Matthew Hoffman’s appointment as scientific director (SD) official in July 2018 after he served two years as Deputy SD.
First Recipient of NIDCR Diversity Fellowship Uses Biochemistry to Understand Developmental Disorders
BY CATHERINE EVANS, NIDCR
For biochemist Jason Collins, a postdoc in the National Institute of Dental and Craniofacial Research (NIDCR), it’s the promise of the scientific “aha” moments that keep him coming back to the bench every day.
Describes His Work on Investigating Genetic Regulation of Biological Clocks
BY MANJU BHASKAR, NINDS
Michael Young, who shared the 2017 Nobel Prize in Physiology or Medicine, for discoveries of molecular mechanisms controlling circadian rhythms, came to NIH to talk about his work as part of the Wednesday Afternoon Lecture Series.
Of the over 8,000 trees on the Bethesda campus, 24 are memorial trees and 50 are commemorative trees. Memorial trees honor people; commemorative trees honor an institute, department achievement, or milestone.
Looking for your new podcast obsession? Tune in to Speaking of Science, a new audio show featuring NIH intramural research program (IRP) scientists who are working at the cutting edge of biomedicine.
Tobacco companies have successfully used direct-to-consumer marketing to entice people to continue smoking or take it up again after they’ve quit. The research that comes to these conclusions—being conducted by Stadtman Investigator Kelvin Choi (NCCIH)—was just one of the many projects highlighted at the NIH Behavioral and Social Sciences Research Festival, held on November 27, 2018.
